Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.03
0.00 (0.00%)
At close: May 01, 2025, 3:59 PM
1.01
-2.42%
Pre-market: May 02, 2025, 04:00 AM EDT

Coherus BioSciences Revenue

Coherus BioSciences reported an annual revenue of $266.96M, reflecting a 3.78% growth. For the quarter ending December 31, 2024, Coherus BioSciences generated $54.14M in revenue.
Revenue (ttm)
$266.96M
Revenue Growth
3.78%
Price / Sales Ratio
0.59
Revenue / Employee
$1.17M
Employees
228
Market Cap
119.95M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 266.96M +3.78%
Dec 31, 2023 257.24M +21.89%
Dec 31, 2022 211.04M -35.37%
Dec 31, 2021 326.55M -31.37%
Dec 31, 2020 475.82M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.